Euden Bhutia1, Alok Hemal1, Tribhuvan Pal Yadav1, K L Ramesh2. 1. Department of Neonatology and Pediatric Medicine, PGIMER, Dr. RML Hospital, New Delhi, India. 2. Department of Biochemistry, PGIMER and Dr. RML Hospital, New Delhi, India.
Abstract
BACKGROUND: It is estimated that about 2.5 million people are living with HIV infection in India. Although antiretroviral drugs have been able to reduce the mortality, these drugs have serious side effects one of which is lipodystrophy syndrome. Most of the drugs used in HAART viz, protease inhibitors, stavudine and nevirapine are associated with lipodystrophy. Hence we conducted this study to assess the prevalence of lipodystrophy in HIV infected children on HAART and its associated risk factors. MATERIALS AND METHODS: A cross sectional study was conducted on 80 HIV infected children aged 2-18 years of age who were on stavudine based HAART for ≥ 2 years. These children were assessed for presence of lipodystrophy, its metabolic complications and associated risk factors. RESULTS: Lipodystrophy was observed in 33.7% of children with lipoatrophy being the commonest subtype followed by lipohypertrophy. Older age, increased duration of treatment and dyslipidaemia were found to be associated in patients with lipodystrophy than those without. On further multivariate analysis of independent risk factors only increased duration of treatment was significantly associated with lipodystrophy. No association was found with insulin resistance. CONCLUSION: We observed that lipodystrophy is a common finding in HIV patients treated with HAART for long duration.
BACKGROUND: It is estimated that about 2.5 million people are living with HIV infection in India. Although antiretroviral drugs have been able to reduce the mortality, these drugs have serious side effects one of which is lipodystrophy syndrome. Most of the drugs used in HAART viz, protease inhibitors, stavudine and nevirapine are associated with lipodystrophy. Hence we conducted this study to assess the prevalence of lipodystrophy in HIV infectedchildren on HAART and its associated risk factors. MATERIALS AND METHODS: A cross sectional study was conducted on 80 HIV infectedchildren aged 2-18 years of age who were on stavudine based HAART for ≥ 2 years. These children were assessed for presence of lipodystrophy, its metabolic complications and associated risk factors. RESULTS: Lipodystrophy was observed in 33.7% of children with lipoatrophy being the commonest subtype followed by lipohypertrophy. Older age, increased duration of treatment and dyslipidaemia were found to be associated in patients with lipodystrophy than those without. On further multivariate analysis of independent risk factors only increased duration of treatment was significantly associated with lipodystrophy. No association was found with insulin resistance. CONCLUSION: We observed that lipodystrophy is a common finding in HIVpatients treated with HAART for long duration.
Authors: Grace D Kinabo; Mirte Sprengers; Levina J Msuya; Aisa M Shayo; Henri van Asten; Wil M V Dolmans; Andre J A M van der Ven; Adilia Warris Journal: Pediatr Infect Dis J Date: 2013-01 Impact factor: 2.129
Authors: T Saint-Marc; M Partisani; I Poizot-Martin; F Bruno; O Rouviere; J M Lang; J A Gastaut; J L Touraine Journal: AIDS Date: 1999-09-10 Impact factor: 4.177
Authors: Steve Innes; Mark F Cotton; Richard Haubrich; Maria M Conradie; Margaret van Niekerk; Clair Edson; Helena Rabie; Sonia Jain; Xiaoying Sun; Ekkehard W Zöllner; Stephen Hough; Sara H Browne Journal: BMC Pediatr Date: 2012-11-23 Impact factor: 2.125